Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screens
Cellular Oncology · 2025
DOI: 10.1007/s13402-025-01102-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Oncology, 2025. Verfasst von Tali S Skipper und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Oncology Group, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia. tali.s.skipper@st…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Drug Resistance, Neoplasm, Gene Knockout Techniques, CRISPR-Cas Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Technology Sydney.
Abstract (Originalsprache)
Understanding genetic dependencies in cancer is key to identifying novel actionable drug targets to advance precision medicine. Whole-genome CRISPR-knockout library screening methods have facilitated this goal. Pooled libraries of single guide RNAs (sgRNAs) targeting over 90% of the annotated protein coding genome are used to induce gene knockouts in pre-clinical cancer models. Novel genes of interest are identified by evaluating sgRNA dropout or enrichment following selection pressure application. This method is particularly beneficial for researching cancers where effective treatment strategies are limited. One example of a commonly chemoresistant cancer, particularly at relapse, is the low survival malignancy epithelial ovarian cancer (EOC), made up of multiple histotypes with distinct molecular profiles. CRISPR-knockout library screens in pre-clinical EOC models have demonstrated the ability to predict biomarkers of treatment response, identify targets synergistic with standard-of-care chemotherapy, and determine novel actionable targets which are synthetic lethal with cancer-associated mutations. Robust experimental design of CRISPR-knockout library screens, including the selection of strong pre-clinical cell line models, allows for meaningful conclusions to be made. We discuss essential design criteria for the use of CRISPR-knockout library screens to discover genetic dependencies in cancer and draw attention to discoveries with translational potential for EOC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Translational Oncology Group, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia. tali.s.skipper@student.uts.edu.au.
- Translational Oncology Group, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia.
- Dr. John and Anne Chong Lab for Functional Genomics, Charles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Camperdown, NSW, Australia.
- School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
- Respiratory Bioinformatics and Molecular Biology Group, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia.
- Translational Oncology Group, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia. deborah.marsh@uts.edu.au.
ORCID-Profile: Tali S Skipper, Kristie-Ann Dickson, Christopher E Denes, Matthew A Waller, Tian Y Du, G Gregory Neely, Nikola A Bowden, Alen Faiz, Deborah J Marsh
Förderung
- University of Technology Sydney
Zitieren
APA
Skipper, T. S., Dickson, K. A., Denes, C. E., Waller, M. A., Du, T. Y., Neely, G. G., Bowden, N. A., Faiz, A., & Marsh, D. J. (2025). Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screens. Cellular Oncology. https://doi.org/10.1007/s13402-025-01102-4
Vancouver
Skipper TS, Dickson KA, Denes CE, Waller MA, Du TY, Neely GG, et al. Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screens. Cellular Oncology. 2025. doi:10.1007/s13402-025-01102-4
BibTeX
@article{Skipper2025,
author = {Skipper, Tali S and Dickson, Kristie-Ann and Denes, Christopher E and Waller, Matthew A and Du, Tian Y and Neely, G Gregory and Bowden, Nikola A and Faiz, Alen and Marsh, Deborah J},
title = {Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screens},
journal = {Cellular Oncology},
year = {2025},
doi = {10.1007/s13402-025-01102-4}
}
EUVIMED